New London lab aims to detect childhood diseases before symptoms appear
The Children's Health Research Institute in London, Ontario, has opened a pediatric lab using Olink technology to analyze proteins from tiny blood samples. This allows for earlier detection of childhood diseases and more personalized treatment plans before symptoms manifest.
Why it matters
This advancement significantly improves diagnostic capabilities for infants and children, where traditional blood collection is difficult and risky.
The Children's Health Research Institute (CHRI), part of the London Health Sciences Centre Research Institute, has opened Canada's first pediatric laboratory certified to use Olink technology, allowing scientists to measure thousands of proteins from a single drop of blood.
The technology allows researchers to identify subtle changes in proteins before symptoms appear, helping them better understand how diseases develop, monitor their progression and identify opportunities for earlier diagnosis and treatment.
"This technology changes the way we study childhood disease," said Dr. Victor Han, scientific director of the Children's Health Research Institute, in a statement Thursday.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in